

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of histone H3-K27 methylation (GO:0061085) | 4.63295947 |
| 2 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.62096982 |
| 3 | mannose metabolic process (GO:0006013) | 4.50726104 |
| 4 | histone H3-K36 demethylation (GO:0070544) | 4.31974543 |
| 5 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06560601 |
| 6 | histone H3-K4 trimethylation (GO:0080182) | 4.03742968 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.95057072 |
| 8 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.80622306 |
| 9 | regulation of gamma-delta T cell activation (GO:0046643) | 3.70199859 |
| 10 | histone lysine demethylation (GO:0070076) | 3.64023025 |
| 11 | negative regulation of myotube differentiation (GO:0010832) | 3.61562985 |
| 12 | histone H3-K4 methylation (GO:0051568) | 3.59982628 |
| 13 | histone H3-K9 demethylation (GO:0033169) | 3.58656663 |
| 14 | regulation of RNA export from nucleus (GO:0046831) | 3.49890755 |
| 15 | histone demethylation (GO:0016577) | 3.47592954 |
| 16 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.42142149 |
| 17 | embryonic process involved in female pregnancy (GO:0060136) | 3.36130816 |
| 18 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.29571031 |
| 19 | definitive hemopoiesis (GO:0060216) | 3.25900126 |
| 20 | dosage compensation (GO:0007549) | 3.25472737 |
| 21 | nuclear pore complex assembly (GO:0051292) | 3.25081315 |
| 22 | glucocorticoid receptor signaling pathway (GO:0042921) | 3.24269780 |
| 23 | response to muramyl dipeptide (GO:0032495) | 3.23312547 |
| 24 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.17227229 |
| 25 | histone H3-K9 modification (GO:0061647) | 3.14479573 |
| 26 | histone lysine methylation (GO:0034968) | 3.12529969 |
| 27 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.11439276 |
| 28 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.09007624 |
| 29 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.03667907 |
| 30 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.03363684 |
| 31 | negative regulation of histone methylation (GO:0031061) | 3.02785336 |
| 32 | corticosteroid receptor signaling pathway (GO:0031958) | 3.02595128 |
| 33 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.02491742 |
| 34 | thymic T cell selection (GO:0045061) | 3.02329864 |
| 35 | regulation of ARF protein signal transduction (GO:0032012) | 3.02013618 |
| 36 | positive regulation of granulocyte differentiation (GO:0030854) | 3.02003158 |
| 37 | negative thymic T cell selection (GO:0045060) | 3.00643808 |
| 38 | protein demethylation (GO:0006482) | 2.99284860 |
| 39 | protein dealkylation (GO:0008214) | 2.99284860 |
| 40 | cellular response to ethanol (GO:0071361) | 2.97454590 |
| 41 | B cell receptor signaling pathway (GO:0050853) | 2.93314054 |
| 42 | positive thymic T cell selection (GO:0045059) | 2.92880051 |
| 43 | regulation of necroptotic process (GO:0060544) | 2.90793260 |
| 44 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.84587247 |
| 45 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.83172741 |
| 46 | negative T cell selection (GO:0043383) | 2.80821516 |
| 47 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.80677085 |
| 48 | positive T cell selection (GO:0043368) | 2.78771583 |
| 49 | histone H3-K9 methylation (GO:0051567) | 2.78701844 |
| 50 | iron ion import (GO:0097286) | 2.78640803 |
| 51 | T cell selection (GO:0045058) | 2.77898366 |
| 52 | regulation of ARF GTPase activity (GO:0032312) | 2.73650108 |
| 53 | positive regulation of histone deacetylation (GO:0031065) | 2.73475824 |
| 54 | stress granule assembly (GO:0034063) | 2.71985392 |
| 55 | response to laminar fluid shear stress (GO:0034616) | 2.70623748 |
| 56 | peptidyl-lysine trimethylation (GO:0018023) | 2.69533315 |
| 57 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.68831101 |
| 58 | histone H4 deacetylation (GO:0070933) | 2.68320513 |
| 59 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.68189975 |
| 60 | peptidyl-lysine methylation (GO:0018022) | 2.66301715 |
| 61 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.65586025 |
| 62 | germinal center formation (GO:0002467) | 2.63001975 |
| 63 | focal adhesion assembly (GO:0048041) | 2.62196503 |
| 64 | cell-substrate adherens junction assembly (GO:0007045) | 2.62196503 |
| 65 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.61959589 |
| 66 | peptidyl-lysine dimethylation (GO:0018027) | 2.61518429 |
| 67 | nuclear pore organization (GO:0006999) | 2.59355946 |
| 68 | striated muscle atrophy (GO:0014891) | 2.57056149 |
| 69 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.56439723 |
| 70 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.55720840 |
| 71 | negative regulation of cell killing (GO:0031342) | 2.55720840 |
| 72 | adherens junction assembly (GO:0034333) | 2.55545652 |
| 73 | histone methylation (GO:0016571) | 2.54996535 |
| 74 | pre-miRNA processing (GO:0031054) | 2.53805313 |
| 75 | negative regulation of fatty acid transport (GO:2000192) | 2.51523529 |
| 76 | protein K48-linked deubiquitination (GO:0071108) | 2.50726297 |
| 77 | positive regulation of protein deacetylation (GO:0090312) | 2.49912380 |
| 78 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.49785853 |
| 79 | RNA stabilization (GO:0043489) | 2.49753913 |
| 80 | mRNA stabilization (GO:0048255) | 2.49753913 |
| 81 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.47258574 |
| 82 | regulation of chromatin binding (GO:0035561) | 2.46916573 |
| 83 | histone H3 deacetylation (GO:0070932) | 2.46305325 |
| 84 | Peyers patch development (GO:0048541) | 2.45391577 |
| 85 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.45391577 |
| 86 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.45201337 |
| 87 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.44916793 |
| 88 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.44110208 |
| 89 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.43744747 |
| 90 | skeletal muscle adaptation (GO:0043501) | 2.43425229 |
| 91 | response to epidermal growth factor (GO:0070849) | 2.43116374 |
| 92 | regulation of histone H3-K4 methylation (GO:0051569) | 2.42945599 |
| 93 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.42478615 |
| 94 | peptidyl-threonine phosphorylation (GO:0018107) | 2.42054255 |
| 95 | face development (GO:0060324) | 2.41229754 |
| 96 | histone H4-K16 acetylation (GO:0043984) | 2.41076752 |
| 97 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.38485881 |
| 98 | coronary vasculature morphogenesis (GO:0060977) | 2.35658171 |
| 99 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.35322612 |
| 100 | endothelial cell chemotaxis (GO:0035767) | 2.32472856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 3.90077071 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.21321716 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.17232665 |
| 4 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.93342617 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.89321695 |
| 6 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.87275697 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.86463825 |
| 8 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.57336178 |
| 9 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.56871305 |
| 10 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.55433669 |
| 11 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.47854019 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.46765690 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.36327901 |
| 14 | * MAF_26560356_Chip-Seq_TH1_Human | 2.25769907 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.13547942 |
| 16 | GATA1_19941826_ChIP-Seq_K562_Human | 2.10759842 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.10108868 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.09267471 |
| 19 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.04988652 |
| 20 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.03308459 |
| 21 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 2.02901558 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 2.01507433 |
| 23 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.00142472 |
| 24 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.97919328 |
| 25 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.97881691 |
| 26 | GATA1_22025678_ChIP-Seq_K562_Human | 1.93265765 |
| 27 | KDM2B_26808549_Chip-Seq_K562_Human | 1.89503497 |
| 28 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.88846452 |
| 29 | * MAF_26560356_Chip-Seq_TH2_Human | 1.88601625 |
| 30 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.82944905 |
| 31 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.77937182 |
| 32 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.72772385 |
| 33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.72271633 |
| 34 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.71921799 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71119017 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.69864829 |
| 37 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.64453429 |
| 38 | * MYB_26560356_Chip-Seq_TH1_Human | 1.62421321 |
| 39 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.61150580 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.59964618 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.59076488 |
| 42 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.57323600 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56246758 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.55103189 |
| 45 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.54528490 |
| 46 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51877343 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.51305285 |
| 48 | GATA2_19941826_ChIP-Seq_K562_Human | 1.48560905 |
| 49 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.46739668 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.45618769 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.45103579 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.44745358 |
| 53 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.43972910 |
| 54 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.43350011 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.42835099 |
| 56 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.42602868 |
| 57 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.39355087 |
| 58 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.37325360 |
| 59 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.37108335 |
| 60 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.35370776 |
| 61 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.35366236 |
| 62 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.33883786 |
| 63 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.30719689 |
| 64 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30685701 |
| 65 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.28600202 |
| 66 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.28341498 |
| 67 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28253473 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.25006861 |
| 69 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23958742 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.23364946 |
| 71 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.21951965 |
| 72 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.21771643 |
| 73 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.20930360 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19689089 |
| 75 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18924201 |
| 76 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18396896 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16330515 |
| 78 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.16041796 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.14673208 |
| 80 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.10459492 |
| 81 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08925014 |
| 82 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.07230032 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06405703 |
| 84 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05476911 |
| 85 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.04360248 |
| 86 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.04177361 |
| 87 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.04123515 |
| 88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03612041 |
| 89 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02176519 |
| 90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.01014429 |
| 91 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00592111 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.98816011 |
| 93 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.98740296 |
| 94 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98087592 |
| 95 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.96962579 |
| 96 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95621269 |
| 97 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94674006 |
| 98 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93194766 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92863849 |
| 100 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.90908591 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005076_abnormal_cell_differentiation | 3.56381586 |
| 2 | MP0003705_abnormal_hypodermis_morpholog | 3.08245709 |
| 3 | MP0008057_abnormal_DNA_replication | 2.97657220 |
| 4 | MP0002009_preneoplasia | 2.94352211 |
| 5 | MP0003763_abnormal_thymus_physiology | 2.85274939 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.68493246 |
| 7 | MP0005451_abnormal_body_composition | 2.54937843 |
| 8 | MP0009278_abnormal_bone_marrow | 2.43471594 |
| 9 | MP0003436_decreased_susceptibility_to | 2.32909736 |
| 10 | MP0004808_abnormal_hematopoietic_stem | 2.07686638 |
| 11 | MP0005409_darkened_coat_color | 2.03554389 |
| 12 | MP0003656_abnormal_erythrocyte_physiolo | 2.00847847 |
| 13 | MP0004947_skin_inflammation | 1.97795338 |
| 14 | MP0008961_abnormal_basal_metabolism | 1.96010550 |
| 15 | MP0003091_abnormal_cell_migration | 1.84515004 |
| 16 | MP0003300_gastrointestinal_ulcer | 1.82224692 |
| 17 | MP0004381_abnormal_hair_follicle | 1.79185747 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 1.76731756 |
| 19 | MP0003303_peritoneal_inflammation | 1.75578517 |
| 20 | MP0003045_fibrosis | 1.75470620 |
| 21 | MP0003172_abnormal_lysosome_physiology | 1.72942320 |
| 22 | MP0001800_abnormal_humoral_immune | 1.72387751 |
| 23 | MP0000703_abnormal_thymus_morphology | 1.70576212 |
| 24 | MP0001545_abnormal_hematopoietic_system | 1.68666658 |
| 25 | MP0005397_hematopoietic_system_phenotyp | 1.68666658 |
| 26 | MP0001873_stomach_inflammation | 1.65263620 |
| 27 | MP0001835_abnormal_antigen_presentation | 1.65210495 |
| 28 | MP0008260_abnormal_autophagy | 1.64658747 |
| 29 | MP0002398_abnormal_bone_marrow | 1.64537131 |
| 30 | MP0000685_abnormal_immune_system | 1.58014363 |
| 31 | MP0004185_abnormal_adipocyte_glucose | 1.57879232 |
| 32 | MP0004130_abnormal_muscle_cell | 1.51353283 |
| 33 | MP0002166_altered_tumor_susceptibility | 1.49634553 |
| 34 | MP0002249_abnormal_larynx_morphology | 1.45750194 |
| 35 | MP0000733_abnormal_muscle_development | 1.43130469 |
| 36 | MP0009115_abnormal_fat_cell | 1.42134925 |
| 37 | MP0005083_abnormal_biliary_tract | 1.41598659 |
| 38 | MP0005666_abnormal_adipose_tissue | 1.40971867 |
| 39 | MP0004233_abnormal_muscle_weight | 1.39332098 |
| 40 | MP0001348_abnormal_lacrimal_gland | 1.38798745 |
| 41 | MP0002722_abnormal_immune_system | 1.36470452 |
| 42 | MP0002405_respiratory_system_inflammati | 1.33016947 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.27574399 |
| 44 | MP0000716_abnormal_immune_system | 1.27405008 |
| 45 | MP0001819_abnormal_immune_cell | 1.27003997 |
| 46 | MP0005387_immune_system_phenotype | 1.24082611 |
| 47 | MP0001790_abnormal_immune_system | 1.24082611 |
| 48 | MP0002723_abnormal_immune_serum | 1.23909543 |
| 49 | MP0005621_abnormal_cell_physiology | 1.22211164 |
| 50 | MP0002419_abnormal_innate_immunity | 1.21980719 |
| 51 | MP0005025_abnormal_response_to | 1.20727526 |
| 52 | MP0000689_abnormal_spleen_morphology | 1.19785734 |
| 53 | MP0002452_abnormal_antigen_presenting | 1.19758233 |
| 54 | MP0005375_adipose_tissue_phenotype | 1.19411054 |
| 55 | MP0003828_pulmonary_edema | 1.16570942 |
| 56 | MP0001849_ear_inflammation | 1.16312232 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.15154988 |
| 58 | MP0002429_abnormal_blood_cell | 1.14503167 |
| 59 | MP0002933_joint_inflammation | 1.14347396 |
| 60 | MP0010155_abnormal_intestine_physiology | 1.13533255 |
| 61 | MP0003866_abnormal_defecation | 1.12255879 |
| 62 | MP0000678_abnormal_parathyroid_gland | 1.10308281 |
| 63 | MP0010307_abnormal_tumor_latency | 1.10243056 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.08949643 |
| 65 | MP0005000_abnormal_immune_tolerance | 1.08101452 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.06685457 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.03335562 |
| 68 | MP0010630_abnormal_cardiac_muscle | 1.03196829 |
| 69 | MP0008995_early_reproductive_senescence | 1.02826192 |
| 70 | MP0003111_abnormal_nucleus_morphology | 0.99249274 |
| 71 | MP0002970_abnormal_white_adipose | 0.97938026 |
| 72 | MP0000858_altered_metastatic_potential | 0.97920091 |
| 73 | MP0002998_abnormal_bone_remodeling | 0.96822131 |
| 74 | MP0005310_abnormal_salivary_gland | 0.93321558 |
| 75 | MP0002086_abnormal_extraembryonic_tissu | 0.93027730 |
| 76 | MP0001851_eye_inflammation | 0.92539935 |
| 77 | MP0004858_abnormal_nervous_system | 0.90142825 |
| 78 | MP0003984_embryonic_growth_retardation | 0.89048751 |
| 79 | MP0002877_abnormal_melanocyte_morpholog | 0.88032900 |
| 80 | MP0009931_abnormal_skin_appearance | 0.87480767 |
| 81 | MP0003115_abnormal_respiratory_system | 0.85684675 |
| 82 | MP0004197_abnormal_fetal_growth/weight/ | 0.83978534 |
| 83 | MP0003690_abnormal_glial_cell | 0.83250026 |
| 84 | MP0002088_abnormal_embryonic_growth/wei | 0.82805870 |
| 85 | MP0005670_abnormal_white_adipose | 0.82101392 |
| 86 | MP0002925_abnormal_cardiovascular_devel | 0.81382929 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81342660 |
| 88 | MP0006138_congestive_heart_failure | 0.79720526 |
| 89 | MP0009333_abnormal_splenocyte_physiolog | 0.79283606 |
| 90 | MP0004043_abnormal_pH_regulation | 0.79236875 |
| 91 | MP0002019_abnormal_tumor_incidence | 0.78592323 |
| 92 | MP0000759_abnormal_skeletal_muscle | 0.75597260 |
| 93 | MP0010352_gastrointestinal_tract_polyps | 0.75525414 |
| 94 | MP0000350_abnormal_cell_proliferation | 0.73972979 |
| 95 | MP0002971_abnormal_brown_adipose | 0.73613418 |
| 96 | MP0004087_abnormal_muscle_fiber | 0.72863495 |
| 97 | MP0001915_intracranial_hemorrhage | 0.70809912 |
| 98 | MP0001730_embryonic_growth_arrest | 0.70633436 |
| 99 | MP0005671_abnormal_response_to | 0.70403823 |
| 100 | MP0002168_other_aberrant_phenotype | 0.69866378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the fingertips (HP:0001211) | 5.21251203 |
| 2 | Dysmetric saccades (HP:0000641) | 3.74971764 |
| 3 | Colitis (HP:0002583) | 3.39586700 |
| 4 | Broad face (HP:0000283) | 3.21585053 |
| 5 | Genetic anticipation (HP:0003743) | 3.18089457 |
| 6 | Obstructive sleep apnea (HP:0002870) | 2.99176918 |
| 7 | Eczematoid dermatitis (HP:0000976) | 2.78867990 |
| 8 | Long eyelashes (HP:0000527) | 2.72020829 |
| 9 | Sparse lateral eyebrow (HP:0005338) | 2.65741912 |
| 10 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.52984223 |
| 11 | Lip pit (HP:0100267) | 2.51497223 |
| 12 | Ankyloglossia (HP:0010296) | 2.48885535 |
| 13 | Hyperacusis (HP:0010780) | 2.47820362 |
| 14 | Dislocated radial head (HP:0003083) | 2.44426625 |
| 15 | Persistence of primary teeth (HP:0006335) | 2.42099900 |
| 16 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.35694417 |
| 17 | Cerebral aneurysm (HP:0004944) | 2.35639185 |
| 18 | Gastrointestinal inflammation (HP:0004386) | 2.32514920 |
| 19 | Flat acetabular roof (HP:0003180) | 2.27728841 |
| 20 | Inflammation of the large intestine (HP:0002037) | 2.26373452 |
| 21 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.24430997 |
| 22 | Narrow palate (HP:0000189) | 2.23213438 |
| 23 | Abnormality of the radial head (HP:0003995) | 2.22825508 |
| 24 | Hemorrhage of the eye (HP:0011885) | 2.21832465 |
| 25 | Heterotopia (HP:0002282) | 2.20463598 |
| 26 | Abnormality of the columella (HP:0009929) | 2.19074639 |
| 27 | Neonatal hypoglycemia (HP:0001998) | 2.13046240 |
| 28 | Sandal gap (HP:0001852) | 2.11563430 |
| 29 | Bowel incontinence (HP:0002607) | 2.10345486 |
| 30 | Reticulocytosis (HP:0001923) | 2.06365873 |
| 31 | Metaphyseal cupping (HP:0003021) | 2.05113347 |
| 32 | Urethral obstruction (HP:0000796) | 2.03481249 |
| 33 | Slow saccadic eye movements (HP:0000514) | 2.02893126 |
| 34 | Increased IgE level (HP:0003212) | 2.02167491 |
| 35 | Onion bulb formation (HP:0003383) | 1.97449754 |
| 36 | Disproportionate tall stature (HP:0001519) | 1.97141083 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.96671515 |
| 38 | Germ cell neoplasia (HP:0100728) | 1.95608332 |
| 39 | Cellulitis (HP:0100658) | 1.95473760 |
| 40 | Aneurysm (HP:0002617) | 1.93480631 |
| 41 | Abnormality of oral frenula (HP:0000190) | 1.92933121 |
| 42 | Gingivitis (HP:0000230) | 1.90854195 |
| 43 | Recurrent viral infections (HP:0004429) | 1.90299496 |
| 44 | Spinal cord lesions (HP:0100561) | 1.90189090 |
| 45 | Syringomyelia (HP:0003396) | 1.90189090 |
| 46 | Prominent nose (HP:0000448) | 1.89513737 |
| 47 | Pustule (HP:0200039) | 1.89500469 |
| 48 | Aortic aneurysm (HP:0004942) | 1.89135077 |
| 49 | Distal lower limb amyotrophy (HP:0008944) | 1.87283418 |
| 50 | Thin bony cortex (HP:0002753) | 1.86911531 |
| 51 | Polycythemia (HP:0001901) | 1.86157725 |
| 52 | Abnormal large intestine physiology (HP:0012700) | 1.85189025 |
| 53 | Anal stenosis (HP:0002025) | 1.85034447 |
| 54 | Recurrent fungal infections (HP:0002841) | 1.84775602 |
| 55 | Spontaneous hematomas (HP:0007420) | 1.84315032 |
| 56 | Macroorchidism (HP:0000053) | 1.83337312 |
| 57 | Seborrheic dermatitis (HP:0001051) | 1.82807913 |
| 58 | Acute myeloid leukemia (HP:0004808) | 1.81989774 |
| 59 | Gastrointestinal infarctions (HP:0005244) | 1.79843404 |
| 60 | Abnormality of the thoracic spine (HP:0100711) | 1.77506706 |
| 61 | Viral hepatitis (HP:0006562) | 1.76702605 |
| 62 | Truncal obesity (HP:0001956) | 1.73733004 |
| 63 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.72646500 |
| 64 | Prolonged bleeding time (HP:0003010) | 1.72320378 |
| 65 | Panhypogammaglobulinemia (HP:0003139) | 1.70445610 |
| 66 | Broad palm (HP:0001169) | 1.69785080 |
| 67 | Asymmetry of the thorax (HP:0001555) | 1.67599358 |
| 68 | Bronchomalacia (HP:0002780) | 1.64448211 |
| 69 | Neoplasm of the heart (HP:0100544) | 1.64441611 |
| 70 | Ulnar bowing (HP:0003031) | 1.63927179 |
| 71 | Interstitial pulmonary disease (HP:0006530) | 1.63334098 |
| 72 | Ureteral stenosis (HP:0000071) | 1.63191768 |
| 73 | Clumsiness (HP:0002312) | 1.61534754 |
| 74 | Tapered finger (HP:0001182) | 1.61148043 |
| 75 | Ureteral obstruction (HP:0006000) | 1.61127634 |
| 76 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.59899781 |
| 77 | Pointed chin (HP:0000307) | 1.59580513 |
| 78 | Obsessive-compulsive behavior (HP:0000722) | 1.59257737 |
| 79 | Thin ribs (HP:0000883) | 1.58980746 |
| 80 | Vertebral arch anomaly (HP:0008438) | 1.58680394 |
| 81 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.56747584 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 1.56747584 |
| 83 | Increased cerebral lipofuscin (HP:0011813) | 1.56395932 |
| 84 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.56220593 |
| 85 | Papilledema (HP:0001085) | 1.55110601 |
| 86 | Mitral valve prolapse (HP:0001634) | 1.54255728 |
| 87 | Thick eyebrow (HP:0000574) | 1.52546658 |
| 88 | Long palpebral fissure (HP:0000637) | 1.52542116 |
| 89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.52128657 |
| 90 | Tented upper lip vermilion (HP:0010804) | 1.51945364 |
| 91 | Subacute progressive viral hepatitis (HP:0006572) | 1.49733813 |
| 92 | Recurrent bacterial skin infections (HP:0005406) | 1.48762239 |
| 93 | Basal cell carcinoma (HP:0002671) | 1.48460648 |
| 94 | Agammaglobulinemia (HP:0004432) | 1.48166229 |
| 95 | Protruding tongue (HP:0010808) | 1.46911276 |
| 96 | Epistaxis (HP:0000421) | 1.45956553 |
| 97 | Exercise-induced myalgia (HP:0003738) | 1.45906793 |
| 98 | Increased connective tissue (HP:0009025) | 1.45669145 |
| 99 | Self-mutilation (HP:0000742) | 1.44393800 |
| 100 | Progressive cerebellar ataxia (HP:0002073) | 1.43741234 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.50658990 |
| 2 | CDK12 | 4.33626776 |
| 3 | ICK | 3.06604445 |
| 4 | EEF2K | 2.92850769 |
| 5 | PRPF4B | 2.75686389 |
| 6 | AKT3 | 2.33901927 |
| 7 | BRD4 | 2.17250101 |
| 8 | FGFR4 | 2.03895225 |
| 9 | MAP3K10 | 2.00914424 |
| 10 | RIPK4 | 1.99746165 |
| 11 | SIK2 | 1.88135931 |
| 12 | PKN2 | 1.86536475 |
| 13 | SIK1 | 1.83595731 |
| 14 | ERN1 | 1.82924450 |
| 15 | BLK | 1.74976636 |
| 16 | MAP4K1 | 1.68915379 |
| 17 | CDC42BPA | 1.67410498 |
| 18 | MAP3K7 | 1.63600852 |
| 19 | SMG1 | 1.58500190 |
| 20 | MARK2 | 1.56603289 |
| 21 | MAP2K3 | 1.56547221 |
| 22 | CAMK1D | 1.56308478 |
| 23 | MTOR | 1.44325968 |
| 24 | MAP3K13 | 1.43103962 |
| 25 | FGFR3 | 1.35088808 |
| 26 | ZAP70 | 1.29969130 |
| 27 | MAP3K6 | 1.28979932 |
| 28 | MAP3K14 | 1.23249328 |
| 29 | RIPK1 | 1.21900130 |
| 30 | TYK2 | 1.20996990 |
| 31 | MAPK11 | 1.20814835 |
| 32 | TTN | 1.17590133 |
| 33 | BTK | 1.16206488 |
| 34 | RET | 1.14285893 |
| 35 | KSR2 | 1.10182887 |
| 36 | CAMK1G | 1.09614310 |
| 37 | TNK2 | 1.09154818 |
| 38 | PDGFRA | 1.07517948 |
| 39 | EPHB1 | 1.06213757 |
| 40 | JAK1 | 1.01526218 |
| 41 | TRPM7 | 0.94123464 |
| 42 | WNK1 | 0.93221006 |
| 43 | GRK6 | 0.91720504 |
| 44 | CDK4 | 0.91252634 |
| 45 | EPHA3 | 0.89071666 |
| 46 | TAOK3 | 0.88057066 |
| 47 | CDK6 | 0.82402281 |
| 48 | JAK3 | 0.81719123 |
| 49 | SGK3 | 0.81200139 |
| 50 | PRKD2 | 0.80908721 |
| 51 | HIPK2 | 0.79119406 |
| 52 | HCK | 0.78808083 |
| 53 | MAPK12 | 0.77383072 |
| 54 | CAMKK1 | 0.76829318 |
| 55 | MELK | 0.76064820 |
| 56 | JAK2 | 0.74132231 |
| 57 | SGK2 | 0.70278119 |
| 58 | TYRO3 | 0.69607804 |
| 59 | STK38 | 0.67482569 |
| 60 | BMX | 0.66932241 |
| 61 | PTK6 | 0.66712171 |
| 62 | NEK6 | 0.65262345 |
| 63 | SYK | 0.64177785 |
| 64 | MAPK7 | 0.63913780 |
| 65 | PDPK1 | 0.63720187 |
| 66 | MST1R | 0.63529659 |
| 67 | PDK1 | 0.61357507 |
| 68 | PRKAA1 | 0.60397368 |
| 69 | PDGFRB | 0.60213193 |
| 70 | FES | 0.59964925 |
| 71 | PRKAA2 | 0.59335863 |
| 72 | LATS1 | 0.58665077 |
| 73 | ITK | 0.58103380 |
| 74 | RPS6KA2 | 0.56427830 |
| 75 | MAPK15 | 0.55896069 |
| 76 | MAP3K2 | 0.55388436 |
| 77 | RPS6KC1 | 0.54701648 |
| 78 | RPS6KL1 | 0.54701648 |
| 79 | LCK | 0.54424134 |
| 80 | MAPK10 | 0.53390161 |
| 81 | MAP3K1 | 0.52018879 |
| 82 | SIK3 | 0.51663562 |
| 83 | SGK223 | 0.50430983 |
| 84 | SGK494 | 0.50430983 |
| 85 | CSK | 0.50330433 |
| 86 | NLK | 0.50305396 |
| 87 | CAMK4 | 0.49916035 |
| 88 | IKBKE | 0.49419670 |
| 89 | RPS6KA6 | 0.46411372 |
| 90 | CHUK | 0.46139663 |
| 91 | MAP2K2 | 0.45821607 |
| 92 | MAPK8 | 0.44722311 |
| 93 | IRAK4 | 0.44417801 |
| 94 | MAPK3 | 0.42787232 |
| 95 | RAF1 | 0.42477391 |
| 96 | MAPK1 | 0.40341758 |
| 97 | MARK3 | 0.39254435 |
| 98 | TBK1 | 0.37535443 |
| 99 | YES1 | 0.36934109 |
| 100 | SGK1 | 0.36391362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.14800656 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.03842993 |
| 3 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.94602986 |
| 4 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.93457849 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.90107489 |
| 6 | Lysine degradation_Homo sapiens_hsa00310 | 1.73785091 |
| 7 | Other glycan degradation_Homo sapiens_hsa00511 | 1.67786532 |
| 8 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.65610518 |
| 9 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.63659753 |
| 10 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.58252336 |
| 11 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.53730238 |
| 12 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.50941440 |
| 13 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.45339491 |
| 14 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.40660235 |
| 15 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.40164139 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38983700 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36838700 |
| 18 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.31234756 |
| 19 | Endometrial cancer_Homo sapiens_hsa05213 | 1.30642276 |
| 20 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.28249110 |
| 21 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.27729082 |
| 22 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.25740671 |
| 23 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.23783341 |
| 24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.23264868 |
| 25 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.23188361 |
| 26 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.22505633 |
| 27 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21875262 |
| 28 | Hepatitis B_Homo sapiens_hsa05161 | 1.19826834 |
| 29 | Prostate cancer_Homo sapiens_hsa05215 | 1.17485231 |
| 30 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.16930951 |
| 31 | Glioma_Homo sapiens_hsa05214 | 1.16008044 |
| 32 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.15812144 |
| 33 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.13314773 |
| 34 | Insulin resistance_Homo sapiens_hsa04931 | 1.10093970 |
| 35 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.10056765 |
| 36 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.09871611 |
| 37 | Colorectal cancer_Homo sapiens_hsa05210 | 1.08600842 |
| 38 | Influenza A_Homo sapiens_hsa05164 | 1.07915471 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07592519 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07526381 |
| 41 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.05921365 |
| 42 | Hepatitis C_Homo sapiens_hsa05160 | 1.05797915 |
| 43 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.04800976 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 1.04686619 |
| 45 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02991170 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02953050 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.00608198 |
| 48 | Measles_Homo sapiens_hsa05162 | 0.98588168 |
| 49 | Thyroid cancer_Homo sapiens_hsa05216 | 0.94301676 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.94072305 |
| 51 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.93491588 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 0.93428049 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91798923 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90920067 |
| 55 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90000743 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.89787386 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88612390 |
| 58 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.88590682 |
| 59 | Bladder cancer_Homo sapiens_hsa05219 | 0.88461874 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88223464 |
| 61 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.84898942 |
| 62 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.84292902 |
| 63 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84201289 |
| 64 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83947712 |
| 65 | Apoptosis_Homo sapiens_hsa04210 | 0.81901806 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81297750 |
| 67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.79898942 |
| 68 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.79849749 |
| 69 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.79825596 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.77619032 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77596892 |
| 72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.76689415 |
| 73 | Adherens junction_Homo sapiens_hsa04520 | 0.76159085 |
| 74 | Long-term potentiation_Homo sapiens_hsa04720 | 0.74900546 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73575928 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.72784829 |
| 77 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71912680 |
| 78 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70607950 |
| 79 | Tuberculosis_Homo sapiens_hsa05152 | 0.70431620 |
| 80 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70236880 |
| 81 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.69678690 |
| 82 | Focal adhesion_Homo sapiens_hsa04510 | 0.67831873 |
| 83 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.66632551 |
| 84 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.65261267 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.62405928 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60423500 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56906696 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56828491 |
| 89 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54855930 |
| 90 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.54100848 |
| 91 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.49897151 |
| 92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.49333165 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.48533786 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.48184287 |
| 95 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46270818 |
| 96 | Circadian rhythm_Homo sapiens_hsa04710 | 0.45992708 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.44815835 |
| 98 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.44503838 |
| 99 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44212064 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | 0.41727072 |

